Pregnancy After Cardiac Valve Replacement

  • Kazuya Kawamata


Pregnancy after heart valve replacement is highly risky for both the mother and child due to the aggravation of maternal heart function and the adverse effects of some drugs, such as anticoagulant or antiarrhythmic drugs.

The recent decrease in the prevalence of rheumatic heart disease among young women has also decreased the use of mechanical heart valves. Developments in cardiac surgery have replaced mechanical heart valves with bioprosthetic heart valves. However, advances in cardiac surgery have even enabled women with mechanical heart valves to survive for a long term. For such women, long-term management of coagulability is absolutely necessary. The management of pregnancy after mechanical valve replacement is most difficult due to this need for anticoagulant therapy.


Pregnancy after cardiac valve replacement Mechanical valve Bioprosthetic valve Ross procedure 


  1. 1.
    North RA, Sadler L, Stewart AW, McCowan LM, Kerr AR, White HD (1999) Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation 99:2669–2676CrossRefGoogle Scholar
  2. 2.
    American College of Obstetricians and Gynecologists: Cardiac diseases in pregnancy. Technical Bulletin No 168, 1992Google Scholar
  3. 3.
    Elkayam U, Bitar F (2005) Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol 46:403–410CrossRefGoogle Scholar
  4. 4.
    Cleuziou J, Hörer J, Kaemmerer H, Teodorowicz A, Kasnar-Samprec J, Schreiber C, Lange R (2010) Pregnancy does not accelerate biological valve degeneration. Int J Cardiol 145(3):418–421. Epub 2010 Jun 3CrossRefPubMedGoogle Scholar
  5. 5.
    Hanania G, Thomas D, Michel PL, Garbarz E, Age C, Millaire A, Acar J (1994) Pregnancy and prosthetic heart valves: a French cooperative retrospective study of 155 cases. Eur Heart J 15(12):1651–1658CrossRefGoogle Scholar
  6. 6.
    Taylor J (2011) The first ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 32:3055–3056CrossRefGoogle Scholar
  7. 7.
    Chan WS, Anand S, Ginsberg JS (2000) Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 160:191–196CrossRefGoogle Scholar
  8. 8.
    Nassar AH, Hobeika EM, Abd Essamad HM, Taher A, Khalil AM, Usta IM (2004) Pregnancy outcome in women with prosthetic heart valves. Am J Obstet Gynecol 191:1009–1013CrossRefGoogle Scholar
  9. 9.
    Greer IA (2002) Exploring the role of low-molecular-weight heparins in pregnancy. Semin Thromb Hemost 28(Suppl 3):25–31CrossRefGoogle Scholar
  10. 10.
    Hall JG, Pauli RM, Wilson KM (1980) Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68:122–140CrossRefGoogle Scholar
  11. 11.
    Ayhan A, Yapar EG, Yuce K, Kisnisci HA, Nazli N, Ozmen F (1991) Pregnancy and its complications after cardiac valve replacement. Int J Gynaecol Obstet 35:117–122CrossRefGoogle Scholar
  12. 12.
    Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO, American College of Chest Physicians (2012) VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e691S–e736S. Scholar
  13. 13.
    Kaneko T, Aranki SF (2013) Anticoagulation for prosthetic valves. Thrombosis 2013:346752. Epub 2013 Nov 4. ReviewCrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kawamata K (2007) Risk and pregnancy outcome in women with prosthetic mechanical heart valve replacement. Circ J 71:211–213CrossRefGoogle Scholar
  15. 15.
    Inoue H, Nozawa T, Okumura K, Iwasa A, Lee JD, Shimizu A et al (2004) Attitudes of Japanese cardiologists toward anticoagulation for non- valvular atrial fibrillation and reasons for its underuse. Circ J 68:417–421CrossRefGoogle Scholar
  16. 16.
    Nozawa T, Inoue H, Iwasa A, Okumura K, Jong-dae L, Shimizu A et al (2004) Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation. Circ J 68:29–34CrossRefGoogle Scholar
  17. 17.
    Uetsuka Y, Hosoda S, Kasanuki H, Aosaki M, Murasaki K, Ooki K et al (2000) Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: a preliminary report from a single institution using conversion from thrombotest to PT-INR. Heart Vessel 15:124–128CrossRefGoogle Scholar
  18. 18.
    Yamaguchi T (2000) Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial: Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke 31:817–821CrossRefGoogle Scholar
  19. 19.
    Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M (1999) Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33:1637–1641CrossRefGoogle Scholar
  20. 20.
    McKenna R, Cole ER, Vasan U (1983) Is warfarin sodium contraindicated in the lactating mother? J Pediatr 103(2):325–327CrossRefGoogle Scholar
  21. 21.
    El-Hamamsy I, Eryigit Z, Stevens LM et al (2010) Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet 376:524–531CrossRefGoogle Scholar
  22. 22.
    Morimoto K, Hoashi T, Kagisaki K et al (2015) Impact of Ross operation on outcome in young female adult patients wanting to have children. Circ J 79(9):1976–1983CrossRefGoogle Scholar
  23. 23.
    Dore A, Somerville J (1997) Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J 18:1659–1662CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2019

Authors and Affiliations

  • Kazuya Kawamata
    • 1
  1. 1.Aiiku HospitalKagoshimaJapan

Personalised recommendations